Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06134167 · ClinicalTrials.gov registry record · Phase 3
A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants With Transfemoral Amputations
A Phase 3 study of Prosthesis and Implants, sponsored by Balmoral Medical company.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
- 9
- Study locations
NCT06134167 is a Phase 3 study of Prosthesis and Implants that is actively recruiting participants, run by Balmoral Medical company. The registered enrollment target is 100 participants. The trial reports 9 study locations across 7 states.
The verdict
NCT06134167, a Phase 3 study of Prosthesis and Implants, is actively recruiting participants, sponsored by Balmoral Medical company.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
- 9
- Study locations
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Transdermal Compress device in participants with Transfemoral Amputations.
Conditions Studied
Interventions
- DEVICE Transdermal Compress Device
Study Locations (9)
Maryland
- The Johns Hopkins Hospital - Baltimore
- Walter Reed Military Medical Center - Bethesda
Pennsylvania
- Penn Medicine; University of Pennsylvania Health System - Philadelphia
- University of Pittsburgh Medical Center - Pittsburgh
California
- UC Davis Medical Center - Sacramento
Colorado
- University of Colorado Anschutz Medical Campus - Aurora
Illinois
- Northwestern Memorial Hospital - Chicago
New York
- Memorial Sloan Kettering Cancer Center - New York
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-06-11 |
| Est. Completion | 2031-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06134167
The ClinicalTrials.gov registry entry for NCT06134167 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Balmoral Medical company, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prosthesis and Implants appearing as the primary indexed condition, and to 1 intervention - of which Transdermal Compress Device is the first listed.
NCT06134167 reports 9 study locations spanning 7 distinct geographic areas - top geographies include Maryland, Pennsylvania, California.
Frequently Asked Questions
What is clinical trial NCT06134167 about?
NCT06134167 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness Transdermal Compress Device in Participants With Transfemoral Amputations". The purpose of this study is to evaluate the safety and effectiveness of the Transdermal Compress device in participants with Transfemoral Amputations.
What is the current status of trial NCT06134167?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2024-06-11. Estimated completion is 2031-06.
What conditions does trial NCT06134167 study?
This clinical trial studies the following conditions: Prosthesis and Implants.
What interventions are being tested in trial NCT06134167?
The interventions under investigation include: Transdermal Compress Device (DEVICE).
Who is sponsoring clinical trial NCT06134167?
This trial is sponsored by Balmoral Medical company, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06134167 being conducted?
This trial has 9 study locations across California, Colorado, Illinois, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.